Skip to main navigation Skip to search Skip to main content

Phase III trial of paclitaxel at two dose levels, the higher dose accompanied by filgrastim at two dose levels in platinum-pretreated epithelial ovarian cancer: an intergroup study.

  • George A. Omura
  • , Mark F. Brady
  • , Katherine Y. Look
  • , Hervy E. Averette
  • , James E. Delmore
  • , Harry J. Long
  • , Scott Wadler
  • , Gregory Spiegel
  • , Susan G. Arbuck
  • University of Alabama at Birmingham

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalJournal of Clinical Oncology
Volume21
Issue number15
DOIs
StatePublished - Aug 1 2003

Disciplines

  • Endocrinology
  • Medicine and Health Sciences
  • Urology
  • Survival Analysis
  • Internal Medicine

Cite this